Review of Vitalhub Corp.

SEP 11, 2025 - VHI’s track record of compounding capital at a high rate as an acquisitive company is still early but quite solid. We think that if the company manages to execute its acquisitive growth playbook consistently. VHI can continue to grow revenue and earnings in the double-digit range for many years. We think the company is currently trading at a fair valuation; we would be comfortable holding it for the long term. However, as prospective shareholders, we would not be too aggressive in adding to the position at the current price; we are upgrading our rating to B+.

Download Report

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Vitalhub Corp. (VHI $8.10)
- $8.10 P/E (TTM): 159.61X Cap: $511M
- View VHI Profile
- View Questions on VHI
- View Reports on VHI

Q: Is Vitalhub considered a SAAS company? If so is this a possible reason for decline or is there another cause.
Matthew

Read Answer Asked by Matthew on February 03, 2026

Constellation Software Inc. (CSU $2,434.02)
- $2,434.02 P/E (TTM): 56.66X Cap: $51.58B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
Vitalhub Corp. (VHI $8.10)
- $8.10 P/E (TTM): 159.61X Cap: $511M
- View VHI Profile
- View Questions on VHI
- View Reports on VHI

Q: Hi Team,
I hold VHI in my tfsa, down 20% now. Would it be considered a "high grade" move to sell it now and buy CSU now that it is also down as much or more than VHI in the last year? Would my return prospects from here with CSU be just as high as compared to sticking with VHI? Would you advise this move?

Thanks,
Shane.

Read Answer Asked by Shane on January 23, 2026

Vitalhub Corp. (VHI $8.10)
- $8.10 P/E (TTM): 159.61X Cap: $511M
- View VHI Profile
- View Questions on VHI
- View Reports on VHI

Q: Hello
Could you please clarify as in some answers recently, the response has been to buy the stock , Vitalhub but the last response was to hold. Here is an analyst view as of today's globe , "Mr. Tse also singled out VitalHub Corp. (VHI-T +3.10%increase
, “outperform” and $16 target) as being a “potential upside surprise” during earnings season.

“We believe the company has been conservative with its margin outlook given its record of surfacing synergies post acquisitions,” he said. “We see upside potential to EBITDA in either the following results and/or forward-looking outlook.”Mr Tse is National Bank Analyst.

The view seems to buy VHI. Can you please clarify?

Read Answer Asked by umedali on January 27, 2026